Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intraoperative lidocaine infusion and postoperative recovery in esophageal cancer surgery
ChiCTR2100041715Phase 4Recruiting
- Sponsor
- Fujian Provincial Hospital
- Start
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of lidocaine in esophageal cancer (2 arms), sponsored by Fujian Provincial Hospital. Primary endpoint: Postoperative recovery quality (QoR-15). Started Jan 2021; status: recruiting.
02
Drugs
lidocaine
03
Conditions
esophageal cancer
Beyond the preview
Go deeper on ChiCTR2100041715.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100041715.